GSA 2025 Abstract·3 JanThe Internet-Based Conversational Engagement Trial (I-CONECT): Theoretical Framework and Latest Findings.Trial in peopleInterventionsPaper
GSA 2025 Abstract·3 JanCombined impact of plasma phospho-tau 217, GFAP and NfL on longitudinal domain-specific cognitive declineStudy in peopleBiomarkersPaper
GSA 2025 Abstract·3 JanChanges in Conversational Pattern as a Clinical Trial Outcome Using the I-CONECT DataTrial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecDigital twins techniques in the design of Alzheimer’s disease clinical trials: an application to the Internet‐Based Conversational Engagement Clinical Trial (I‐CONECT)Trial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecShort‐interval common game play distinguishes people with and without cognitive impairmentStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecAssociations between plasma biomarkers and longitudinal neuropsychiatric symptoms across the cognitive spectrum in older adults: findings from the Massachusetts Alzheimer's Disease Research CenterStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecChanges in conversational pattern as a clinical trial outcome using the I‐CONECT dataTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecThe Internet‐Based Conversational Engagement Trial (I‐CONECT) for Socially Isolated Older Adults: Conceptual Framework and Latest FindingsTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecInternet‐Based Conversational Engagement Clinical Trial (I‐CONECT): Overview and new findingsTrial in peopleInterventionsPaper
GSA 2024 Abstract·1 JanTARGETING SOCIALLY ISOLATED OLDER ADULTS: THE INTERNET-BASED CONVERSATIONAL ENGAGEMENT TRIAL (I-CONECT)Trial in peopleInterventionsPaper